Mirum Pharmaceuticals

MIRM · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings about 1 month ago

Total Revenue

$149M

Previous year: $99.4M

+49.8%

EPS

-$0.11

Previous year: -$1.85

Previous year: $56.8M

+30.4%

Total Operating Expenses

Loading...

Mirum Pharmaceuticals

Unlock previous datapoints

Upgrade

Mirum Pharmaceuticals

Unlock previous datapoints

Upgrade

Mirum Pharmaceuticals Revenue by Segment

Revenue by Segment

Net Product Sales Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$5.3B

P/E Ratio

-196.49

Sector

N/A

Industry

N/A

52-Week High

$109

52-Week Low

$38.3

R&D Expenses

$51.1M

SG&A Expenses

$74.1M

Total Operating Expenses

$153M

Interest Income

$3.42M

Interest Expense

$3.6M

Products

Get in Touch

Resources

Mirum Pharmaceuticals

Mirum Pharmaceuticals

Mirum Pharmaceuticals

Mirum Pharmaceuticals Revenue by Segment

Revenue by Segment

Net Product Sales Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics